"This 2024 cohort study evaluates the diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. Utilizing a precise immunoassay, we assessed plasma p-tau217 levels in a cohort of patients, demonstrating its potential as a reliable biomarker for Alzheimer disease diagnosis, with implications for early detection and intervention."